These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 12801318)

  • 21. Ocular toxicity of systemic asthma and allergy treatments.
    Bielory L
    Curr Allergy Asthma Rep; 2006 Jul; 6(4):299-305. PubMed ID: 16822382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray.
    Murphy K; Uryniak T; Simpson B; O'Dowd L
    Ann Allergy Asthma Immunol; 2006 May; 96(5):723-30. PubMed ID: 16729787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine.
    Stern MA; Wade AG; Ridout SM; Cambell LM
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):354-8. PubMed ID: 9809500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.
    Fokkens WJ; Cserháti E; dos Santos JM; Praca F; van Zanten M; Schade A; Simon G
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):279-84. PubMed ID: 12269648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome.
    Rinne J; Simola M; Malmberg H; Haahtela T
    J Allergy Clin Immunol; 2002 Mar; 109(3):426-32. PubMed ID: 11897986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis.
    Meltzer EO
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis.
    Möller C; Ahlström H; Henricson KA; Malmqvist LA; Akerlund A; Hildebrand H
    Clin Exp Allergy; 2003 Jun; 33(6):816-22. PubMed ID: 12801318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The updated role of budesonide in managing children and adolescents with allergic rhinitis.
    Ciprandi G
    Minerva Pediatr (Torino); 2024 Aug; 76(4):526-536. PubMed ID: 38407014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE
    Drug Saf; 2004; 27(12):883-98. PubMed ID: 15366976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the effect of intranasal steroids on growth.
    Pedersen S
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S40-4. PubMed ID: 11449205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis.
    Wolthers OD
    Acta Paediatr; 2000 Oct; 89(10):1158-61. PubMed ID: 11083368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.